Research/ Academia/ Activities

Research program to elucidate the molecular bio...

Shinko Pharmaceutical Co., Ltd. (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) has launched a series of life science research programs focusing on the mechanism of action and effects of Nicotinamide Mononucleotide...